| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.0M | +604.7% |
| SG&A Expense | $22.5M | +890.8% |
| Operating Income | -$53.6M | -505.7% |
| Interest Expense | $184K | -28.1% |
| Net Income | -$13.7M | — |
| EPS (Basic) | -$0.07 | +97.1% |
| EPS (Diluted) | -$0.07 | +97.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $2.4M | +563.5% |
| Total Assets | $3.5M | -79.7% |
| Current Liabilities | $9.0M | +201.0% |
| Total Liabilities | $10.1M | -42.8% |
| Stockholders' Equity | -$6.7M | +61.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.0M | -771.8% |
| Capital Expenditures | $133K | +0.0% |
| Investing Cash Flow | -$133K | -100.0% |
| Financing Cash Flow | $12.2M | +103.6% |
| Free Cash Flow | -$12.1M | -703.8% |